Results 31 to 40 of about 3,559 (85)

Venetoclax-based therapy in high-risk patients with relapsed/refractory multiple myeloma harboring t(11;14): a case report and review of the literature. [PDF]

J Med Case Rep
Yin J, Zhou X, Zhong Y.
europepmc   +1 more source

Asymmetric synthesis of Heteroatom-bridged [3.2.1]Octane scaffolds via enantioselective β-H elimination reaction. [PDF]

Nat Commun
Fang C, Ai J, Wang Q, Xu B, Zhang J, Zhang ZM.   +5 more
europepmc   +1 more source

Hypomethylating agents plus venetoclax in younger acute myeloid leukemia: Meta-analysis of a shifting treatment paradigm. [PDF]

Cancer
Perrone S, De Fazio L, Monachetti S, Molica M.   +3 more
europepmc   +1 more source

Efficacy of venetoclax combined with azacitidine for advanced blastic plasmacytoid dendritic cell neoplasm: experience from two Japanese cases. [PDF]

J Clin Exp Hematop
Shibamiya A, Ohwada C, Tsutsui Y, Tanaka A, Watanabe R, Akatsuka T, Hamada T, Sugaya M, Hayashi Y, Shiomi T, Nakaseko C.   +10 more
europepmc   +1 more source

Bicyclo[1.1.0]tetragermane-2,4-diide Diradicaloid. [PDF]

Angew Chem Int Ed Engl
Ebeler F, Vishnevskiy YV, Lamm JH, Neumann B, Stammler HG, Ghadwal RS.   +5 more
europepmc   +1 more source

Real-World Selection of Venetoclax-Obinutuzumab Versus BTK Inhibitor Therapy for Treatment-Naïve Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma. [PDF]

Eur J Haematol
Tidswell R, Owen C, Shafey M, Perry S, Cox-Kennett N, Sterrett R, Peters A, Puckrin R.   +7 more
europepmc   +1 more source

A relapsed/refractory acute promyelocytic leukemia achieving complete response after chemotherapy with venetoclax. [PDF]

Medicine (Baltimore)
Zhang X, Hao S, Hu C, Qu R.
europepmc   +1 more source

Trojan horses at leptomeningeal cellular gates: Antibody-drug conjugates deliver cytotoxic payloads. [PDF]

Med
Nikanjam M, Kurzrock R.
europepmc   +1 more source

Catalytic Methods for the Transfer of Nonstabilized Carbenes. [PDF]

ACS Catal
Arnold ES, Eckart-Frank IK, Wilkerson-Hill SM.   +2 more
europepmc   +1 more source

Finite-Duration Venetoclax/Azacitidine Followed by Umbilical Cord Blood Infusion Improves Outcomes in Frail Elderly Patients With Untreated Acute Myeloid Leukemia-A Pilot Study. [PDF]

Cancer Med
Ye L, Xie M, Xu G, Mei C, Hu C, Zhou X, Ren Y, Ma L, Yang C, Qian J, Jin J, Tong H.   +11 more
europepmc   +1 more source